Novo Nordisk A/S (ADR) (NYSE:NVO)

CAPS Rating: 5 out of 5

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

Recs

1
Player Avatar Pumpstick (99.10) Submitted: 4/28/2011 4:12:18 PM : Underperform Start Price: $24.29 NVO Score: -28.72

Maybe a great company, but valution is too high.

Featured Broker Partners


Advertisement